Oculis
Clinical trials sponsored by Oculis, explained in plain language.
-
New drug shows promise for eye nerve inflammation
Disease control CompletedThis study tested a new drug called OCS-05 in 36 people with acute optic neuritis, a condition that causes sudden vision loss due to nerve inflammation. The main goal was to see if the drug is safe and tolerable compared to a placebo, while participants also received standard car…
Phase: PHASE2 • Sponsor: Oculis • Aim: Disease control
Last updated May 17, 2026 08:50 UTC
-
New eye drop could help diabetics see clearly again
Disease control CompletedThis study tested whether OCS 01 eye drops can improve vision in people with diabetic macular edema, a condition where fluid builds up in the eye due to diabetes. About 400 participants used either the eye drop or a placebo. The main goal was to see if the drops help people read …
Phase: PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated May 17, 2026 08:50 UTC
-
Eye drops could offer new hope for diabetic vision loss
Disease control CompletedThis study tested whether OCS-01 eye drops can improve vision in people with diabetic macular edema, a condition where fluid builds up in the eye due to diabetes. The trial involved 552 participants and compared the eye drops to a placebo. The main goal was to see if the drops he…
Phase: PHASE2, PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New eye drop could ease pain and swelling after cataract surgery
Symptom relief CompletedThis study tested an eye drop called OCS 01 in 153 adults who had cataract surgery. The goal was to see if it could reduce eye inflammation and pain better than a placebo drop. Participants used the drop once or twice a day for a short time after surgery.
Phase: PHASE2 • Sponsor: Oculis • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC